Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11168138 Anti-PDL1, IL-15 and TGF-beta receptor combination molecules

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
March 26, 2019
0
Date of Patent
November 9, 2021
0
Patent Applicant
Altor BioScience
Altor BioScience
0
Patent Application Number
20190326
0
Patent Citations Received
‌
US Patent 11992516 Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies
0
‌
US Patent 11498950 Fusion molecules and IL-15 variants
‌
US Patent 11872272 IL-15-based fusions to IL-12 and IL-18
0
‌
US Patent 11890323 Method of treating cancer with composition comprising IL-15-based molecules and BCG
0
‌
US Patent 11925676 Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex
0
‌
US Patent 11975059 IL-15-based fusions to IL-12 and IL-18
0
Patent Inventor Names
Xiaoyun Zhu
0
Hing C. Wong
0
Qiongzhen Li
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11168138
0
Patent Primary Examiner
‌
Bridget E Bunner
0

Find more entities like US Patent 11168138 Anti-PDL1, IL-15 and TGF-beta receptor combination molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo